- Home
- TANH vs BDRX Comparison
TANH vs BDRX Comparison
Compare TANH & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TANH
- BDRX
- Stock Information
- Founded
- TANH 2001
- BDRX 2000
- Country
- TANH China
- BDRX United Kingdom
- Employees
- TANH N/A
- BDRX N/A
- Industry
- TANH
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- TANH
- BDRX Health Care
- Exchange
- TANH Nasdaq
- BDRX Nasdaq
- Market Cap
- TANH 3.2M
- BDRX 3.2M
- IPO Year
- TANH 2015
- BDRX N/A
- Fundamental
- Price
- TANH $1.11
- BDRX $5.20
- Analyst Decision
- TANH
- BDRX
- Analyst Count
- TANH 0
- BDRX 0
- Target Price
- TANH N/A
- BDRX N/A
- AVG Volume (30 Days)
- TANH 78.6K
- BDRX 163.9K
- Earning Date
- TANH 01-02-2026
- BDRX 09-12-2025
- Dividend Yield
- TANH N/A
- BDRX N/A
- EPS Growth
- TANH N/A
- BDRX N/A
- EPS
- TANH N/A
- BDRX N/A
- Revenue
- TANH $42,940,136.00
- BDRX N/A
- Revenue This Year
- TANH N/A
- BDRX N/A
- Revenue Next Year
- TANH N/A
- BDRX N/A
- P/E Ratio
- TANH N/A
- BDRX N/A
- Revenue Growth
- TANH N/A
- BDRX N/A
- 52 Week Low
- TANH $1.07
- BDRX $4.88
- 52 Week High
- TANH $10.77
- BDRX $92.00
- Technical
- Relative Strength Index (RSI)
- TANH 27.39
- BDRX 42.34
- Support Level
- TANH $1.10
- BDRX $4.88
- Resistance Level
- TANH $1.18
- BDRX $5.65
- Average True Range (ATR)
- TANH 0.10
- BDRX 0.64
- MACD
- TANH -0.01
- BDRX -0.09
- Stochastic Oscillator
- TANH 10.89
- BDRX 21.89
About TANH Tantech Holdings Ltd.
Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.